// App-Quantinova.ai

POS03 : Use of Absorb bioresorbable scaffolds for the treatment of coronary ostial lesions - Results from the GHOST-EU database

Researchers

Presenter

  • Gori T

Principal Investigators

  • Capodanno D

  • Geraci S

  • Mattesini A

  • Naber C

  • Araszkiewicz A

  • Colombo A

  • Tamburino C

  • Nef H

  • Munzel T

  • Latib A

  • Lesiak M

  • Pyxaras S

  • Mehilli J

  • Caramanno G

  • Di Mario C

  • Weber J

  • Capranzano P

Medical Centers

  • Department of Cardiology, University of Giessen, Giessen, Germany, Giessen, Germany

  • University Medical Center Mainz, Mainz, Germany

  • San Giovanni di Dio Hospital, Agrigento, Italy

  • Department of Cardiology, Klinikum Grosshadern, Ludwig- Maximilian Universitat, Munchen, Germany

  • National Institute of Health Research Cardiovascular BRU, Royal Brompton Hospital & Imperial College, London, United Kingdom

  • Ferrarotto Hospital, University of Catania, Catania, Italy

  • Department of Hematology, Poznan University of Medical Sciences, Poznan,

  • EMO GVM Centro Cuore Columbus/San Raffaele Hospital, Milan, Italy

  • Contilia Heart and Vascular Centre, Elisabeth Krankenhaus Essen, Germany, Essen, Germany

Locations

  • Poland

  • Germany

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Hypertension

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved